![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](hb2408contents.gif)
Acta Cryst. (2007). E63, m1692-m1693 [ doi:10.1107/S1600536807023082 ]
-benzene-1,3-dicarboxylato] N,N-dimethylacetamide monohydrate]Abstract: In the title compound, [Cu(C8H4O4)(C14H8N4)(H2O)]·C4H9NO·H2O, the CuII atom is five-coordinated by three O atoms from two benzene-1,3-dicarboxylate (1,3-bdc) ligands and one water molecule, and two N atoms from one chelating pyrazino[2,3-f][1,10]phenanthroline (L) ligand in a distorted square-pyramidal geometry. The CuII atoms are bridged by the 1,3-bdc ligands to form a one-dimensional helical chain structure. A network of O-H
O hydrogen bonds completes the structure. There are two half-molecules of 1,3-bdc in the asymmetric unit; both complete molecules are generated by twofold rotation symmetry, with two C atoms lying on the rotation axis in each case.
Online 26 May 2007
Copyright © International Union of Crystallography
IUCr Webmaster